Pharmaceutical Risk Management — GMP, GDP, ISO 13485

PHARMA RISKMANAGEMENT
Risk Management for the Pharmaceutical Industry

Manage pharmaceutical production risks with an integrated platform. GMP, GDP, ISO 13485 compliance. Pharmacovigilance, supplier qualification and process validation in a single solution.

Pharmaceutical laboratory with GMP quality control
Industry Challenges

Specific Risks in the Pharmaceutical Industry

The pharmaceutical industry operates under the world's strictest regulations. A single error can compromise patient health and lead to multimillion-pound penalties

Product Recall

Risk of pharmaceutical batches being withdrawn from the market due to process deviations, contaminations or GMP non-conformities, with enormous costs and warning letters from regulators

Regulatory warning letters

Product Liability

Risk that manufactured drugs cause harm to patients with consequent civil liability, market withdrawal and criminal implications for executives

Critical liability

Critical Supplier Loss

Risk of disruption to the supply of active pharmaceutical ingredients (APIs) and raw materials due to loss of a GMP-qualified supplier

Mandatory audits

Sensitive Data Theft

Risk of theft of research data, proprietary formulations, registration dossiers and clinical data, with breach of data integrity and ALCOA+ requirements

ALCOA+ requirement
The Problem

Paper-based deviation management with unacceptable CAPA closure times.
No guaranteed data integrity with untraceable manual records.
Poorly monitored API suppliers with pharmaceutical supply chain risk.
Reactive change control without structured impact assessment.

Pharmaceutical compliance management problems
The Exsafe Solution

Digitalised deviations with CAPA workflow and controlled timelines.
ALCOA+ audit trail on every data point and document in the system.
GMP supplier qualification with audits, scoring and continuous monitoring.
Proactive change control with automated impact assessment.

Discover
Soluzione risk management farmaceutico
Real Use Cases

How Pharmaceutical Companies Use Exsafe

Concrete application scenarios in the pharma and medical devices sector

Sfida

A pharmaceutical company had to proceed with the voluntary recall of 3 batches of an antibiotic due to a process deviation not intercepted in time. The paper-based deviation management system had not generated alerts and the CAPA had been open for 90 days. The recall incurred direct costs of EUR 320K and an urgent communication to the regulator.

Soluzione

The risk analysis with Exsafe Platform identified excessive CAPA closure times and the absence of a link between deviations and distributed batches as the main causes of avoidable recalls, and proposed digitalisation of the process with alert escalation. The company chose to implement automatic deviation classification by criticality, structured root cause analysis and a direct link between deviation, production batch and distribution.

Risultato

Average CAPA closure time reduced to 35 days. No recalls in the 18 months following implementation. Regulatory inspection passed with 0 critical observations on deviation management.

-70% CAPA time0 post-implementation recalls0 regulatory observations

Results in the Pharmaceutical Industry

The numbers from pharmaceutical companies that chose our solution

-70%
CAPA Time

Corrective action closure

0
Warning Letters

Resolved and prevented

92%
Effective CAPAs

Verified effectiveness rate

100%
Data Integrity

ALCOA+ compliance

Guaranteed GMP Compliance

Pass every regulatory inspection with complete and traceable documentation

Reports ready for GMP inspections, client audits and ISO 13485 certifications. Guaranteed data integrity.

See Demo
GMP pharmaceutical laboratory inspection

Frequently Asked Questions - Pharmaceutical Industry

Protect Your Pharmaceutical Production. Start Today.

Request a personalised demo for the pharmaceutical industry and discover how to manage GMP, pharmacovigilance and compliance in a single platform.

Request a demo